Neurotrophic receptor TrkB: Is it a predictor of poor prognosis for carcinoma patients?
- 27 September 2006
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 68 (2) , 407-409
- https://doi.org/10.1016/j.mehy.2006.05.038
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Brain-Derived Neurotrophic Factor Activation of TrkB Induces Vascular Endothelial Growth Factor Expression via Hypoxia-Inducible Factor-1α in Neuroblastoma CellsCancer Research, 2006
- TrkB partial agonists: Potential treatment strategy for epilepsy, mania, and autismMedical Hypotheses, 2006
- Coronary vessel development requires activation of the TrkB neurotrophin receptor by the Wilms' tumor transcription factor Wt1Genes & Development, 2005
- A neurotrophin axis in myeloma: TrkB and BDNF promote tumor-cell survivalBlood, 2005
- Autocrine- and paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphomaBlood, 2005
- Shc Family Expression in Neuroblastoma: High Expression of shcC Is Associated with a Poor Prognosis in Advanced NeuroblastomaClinical Cancer Research, 2005
- Identification of Dynamic Proteome Changes Upon Ligand Activation of Trk-Receptors Using Two-dimensional Fluorescence Difference Gel Electrophoresis and Mass SpectrometryMolecular & Cellular Proteomics, 2005
- Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkBNature, 2004
- Die Expression des Neurotrophin-Rezeptors TrkB beeinflusst die Prognose von Nephroblastomen: Ergebnisse einer PilotstudieKlinische Padiatrie, 2001
- Expression of the Neurotrophin Receptor TrkB Is Associated With Unfavorable Outcome in Wilms’ TumorJournal of Clinical Oncology, 2001